Robert King to Genetic Therapy
This is a "connection" page, showing publications Robert King has written about Genetic Therapy.
Connection Strength
0.268
-
Batista AR, Scholand AC, Callahan WS, Watson MK, Sion CM, Mola T, O'Hara K, Wentworth SA, Sena-Esteves WS, King OD, King RM, Sena-Esteves M. AAV-mediated gene therapy demonstrates phenotypic rescue in a mouse model of Cockayne syndrome. J Clin Invest. 2026 Sep 15; 136(18).
Score: 0.142
-
Ferguson CM, Godinho BM, Alterman JF, Coles AH, Hassler M, Echeverria D, Gilbert JW, Knox EG, Caiazzi J, Haraszti RA, King RM, Taghian T, Puri A, Moser RP, Gounis MJ, Aronin N, Gray-Edwards H, Khvorova A. Comparative route of administration studies using therapeutic siRNAs show widespread gene modulation in Dorset sheep. JCI Insight. 2021 12 22; 6(24).
Score: 0.103
-
Taghian T, Marosfoi MG, Puri AS, Cataltepe OI, King RM, Diffie EB, Maguire AS, Martin DR, Fernau D, Batista AR, Kuchel T, Christou C, Perumal R, Chandra S, Gamlin PD, Bertrand SG, Flotte TR, McKenna-Yasek D, Tai PWL, Aronin N, Gounis MJ, Sena-Esteves M, Gray-Edwards HL. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna. Mol Ther. 2020 02 05; 28(2):411-421.
Score: 0.022